Ceryx Medical develops bioelectronic devices utilizing patented chip technology that mimics physiological signals to enhance cardiac function. Their Cysoni device specifically targets heart failure, aiming to restore cardiac performance and improve patient quality of life.
Funding
$4.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Heart failure, a chronic condition affecting millions, has a poor prognosis with a significant percentage of patients dying within five years of diagnosis. Current treatments often fail to adequately restore cardiac performance or improve the patient's quality of life. Healthcare systems spend a large portion of their budget battling this disease.
Solution
Ceryx Medical develops bioelectronic medical devices that mimic the body's natural physiological signals to improve cardiac function. Their core technology allows devices to interpret these signals and generate a real-time response, simulating the body's natural functions. The Cysoni device, specifically designed for heart failure patients, aims to restore cardiac performance, alleviate symptoms, improve quality of life, and support heart recovery. The device employs biomimetic design principles and patented electronics to communicate with the body in its own language.
Target Audience
The primary target audience includes heart failure patients and healthcare providers seeking advanced treatment options for this chronic condition.
Features
- Bioelectronic technology that mimics natural physiological signals.
- Cysoni device designed specifically for heart failure treatment.
- Real-time interpretation of physiological signals and generation of natural responses.
- Potential to restore cardiac performance and improve heart function.
- Aims to improve the quality of life for heart failure patients.
- Patented electronics for seamless integration with the body's homeostatic systems.